{"effective_time":"20120910","id":"f0bbb5fe-dce7-4561-a0a5-bf0b76749557","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label NDC 0069-0135-01 Pfizer Bosulif ® (bosutinib) tablets 100 mg* Do not crush or cut tablet For Oncology Use Only 120 Tablets Rx only PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label","PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label NDC 0069-0136-01 Pfizer Bosulif ® (bosutinib) tablets 500 mg* Do not crush or cut tablet For Oncology Use Only 30 Tablets Rx only PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label"],"set_id":"dd830d07-438e-4c8e-8118-3a6067b46cb1","spl_product_data_elements":["BOSULIF Bosutinib monohydrate Bosutinib monohydrate Bosutinib cellulose, microcrystalline croscarmellose sodium POVIDONE K25 magnesium stearate polyvinyl alcohol titanium dioxide POLYETHYLENE GLYCOL 3350 talc ferric oxide yellow POLOXAMER 188 biconvex Pfizer;100 BOSULIF Bosutinib monohydrate Bosutinib monohydrate Bosutinib cellulose, microcrystalline croscarmellose sodium POVIDONE K25 magnesium stearate polyvinyl alcohol titanium dioxide POLYETHYLENE GLYCOL 3350 talc ferric oxide red POLOXAMER 188 biconvex Pfizer;500"],"version":"1"}